Related Experiment Video
Updated: Aug 15, 2026

Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized
Daniel J Goldstein1, Helena L Chang2, Michael J Mack3
1Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center, Bronx, NY.
Insights
Intimal hyperplasia in saphenous vein grafts (SVGs) is linked to worse graft disease and more cardiac events after coronary artery bypass grafting (CABG). This impacts long-term patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Vascular Biology
- Clinical Trials
Background:
- Saphenous vein grafts (SVGs) are crucial for coronary artery bypass grafting (CABG), but intimal hyperplasia (IH) and graft irregularity reduce their long-term effectiveness.
- The VEST trial investigated external graft support to mitigate IH development at one year post-surgery.
- This secondary analysis examines the relationship between graft disease, IH, and clinical events, alongside risk factors for early graft occlusion.
Purpose of the Study:
- To explore the associations between graft disease, intimal hyperplasia (IH), and clinical events in patients undergoing coronary artery bypass grafting (CABG).
- To identify risk factors contributing to early saphenous vein graft (SVG) occlusion.
Main Methods:
- A secondary analysis of the VEST trial, a within-patient randomized multicenter study involving 224 patients undergoing CABG.
- Intravascular ultrasound and angiography were used to assess IH, lumen uniformity, stenosis, and graft perfusion at one year post-surgery.
- Major adverse cardiac and cerebrovascular events (MACCE) were recorded over a median follow-up of three years.
Main Results:
- Poorer lumen uniformity, increased graft stenosis, and impaired graft perfusion correlated with higher IH values and more clinical events.
- Endoscopic vein harvesting, female sex, and specific transit time flow measurements were identified as risk factors for SVG occlusion within the first year.
- A significant association was found between IH area and clinical measures of SVG disease at one year.
Conclusions:
- Increased intimal hyperplasia and more severe saphenous vein graft disease are linked to a higher incidence of major adverse cardiac and cerebrovascular events (MACCE) at three years post-coronary artery bypass grafting (CABG).
- Further follow-up to five years is needed to fully understand the long-term impact of SVG disease on clinical outcomes.
Background:
Diffuse intimal hyperplasia and graft irregularity adversely affect the long-term patency of saphenous vein grafts (SVGs) and clinical outcomes of patients undergoing coronary artery bypass grafting (CABG). The VEST trial evaluated the efficacy of external graft support in limiting the development of intimal hyperplasia (IH) at 1 year postsurgery. In the present secondary analysis, we explored the associations between graft disease and IH and clinical events. We also examined risk factors for early graft occlusion.
Methods:
VEST is a within-patient randomized, multicenter trial that enrolled 224 patients with multivessel coronary disease undergoing CABG surgery, of whom 203 were evaluated by 1 year postsurgery. Intimal hyperplasia, lumen uniformity, graft stenosis, and graft perfusion were measured by intravascular ultrasound and angiography. Major cardiac and cerebrovascular events (MACCE; including death, myocardial infarction, stroke, and revascularization) were recorded over a median follow-up of 3 years.
Results:
Worse lumen uniformity, greater stenosis, and worse graft perfusion were associated with higher IH values and an increased incidence of clinical events. Consistent with previous findings, we identified endoscopic vein harvesting, female sex, and transit time flow measurement of pulsatility index and flow as risk factors for SVG occlusion during the first year postsurgery.
Conclusions:
In this secondary analysis of the VEST trial, we observed an association between intimal hyperplasia area and clinical measures of SVG disease at 1 year postsurgery. More severe SVG disease and larger areas of IH were associated with a higher incidence of 3-year MACCE. Ongoing follow-up to 5 years will further elucidate the impact of SVG disease on long-term clinical outcomes of CABG.
More Related Videos
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies